1. Home
  2. CISO vs PYPD Comparison

CISO vs PYPD Comparison

Compare CISO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CISO Global Inc.

CISO

CISO Global Inc.

HOLD

Current Price

$0.33

Market Cap

16.3M

Sector

Technology

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.40

Market Cap

81.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CISO
PYPD
Founded
2015
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3M
81.7M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
CISO
PYPD
Price
$0.33
$4.40
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
129.5K
51.9K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
79.31
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$2.30
52 Week High
$1.70
$5.12

Technical Indicators

Market Signals
Indicator
CISO
PYPD
Relative Strength Index (RSI) 38.92 54.00
Support Level $0.32 $4.14
Resistance Level $0.43 $5.05
Average True Range (ATR) 0.03 0.20
MACD -0.00 0.02
Stochastic Oscillator 15.14 56.49

Price Performance

Historical Comparison
CISO
PYPD

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: